Origin Sciences Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Origin Sciences Limited - overview
Established
2004
Location
Abington, -, UK
Primary Industry
Medical Devices & Equipment
About
Based in Abington, UK, and founded in 2003, Origin Sciences Limited, formerly known as Colonix Medical Limited, operates as a medical device firm that offers colorectal cancer diagnostic devices. The company was founded by Rupert Lywood. Origin Sciences raised venture funding from CSVE Ventures. As of 2023, the company is led by its CEO, Hugo Lywood.
Origin Sciences develops medical devices to aid in the detection and diagnosis of gastrointestinal diseases. The company’s product line includes Oricol, a medical device designed to collect rectal mucosa samples from human subjects, and the collected samples can be used for diagnostic purposes, especially in the context of colorectal cancer (CRC) detection. The firm’s research and validation program targets patients with symptoms of colorectal cancer (CRC) and/or high-risk colorectal pathology.
Primary Industry
Medical Devices & Equipment
Sub Industries
Diagnostic Equipment
Website
www.originsciences.com
Verticals
Manufacturing
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.